LEAKADINE Trademark

Trademark Overview

On Monday, March 20, 2006, a trademark application was filed for LEAKADINE with the United States Patent and Trademark Office. The USPTO has given the LEAKADINE trademark a serial number of 79023570. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, March 20, 2016. This trademark is owned by TETRA, SIA. The LEAKADINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of cancer or dermatological diseases or for modulating immune response
leakadine

General Information

Serial Number79023570
Word MarkLEAKADINE
Filing DateMonday, March 20, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, March 20, 2016
Registration Number3249819
Registration DateTuesday, June 5, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of cancer or dermatological diseases or for modulating immune response

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 10, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTETRA, SIA
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLV
Party NameTETRA, SIA
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLV
Party NameTETRA, SIA
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLV

Trademark Events

Event DateEvent Description
Friday, October 21, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, October 21, 2016DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 6, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, April 3, 2015GENERIC MADRID TRANSACTION SENT TO IB
Friday, April 3, 2015GENERIC MADRID TRANSACTION CREATED
Wednesday, September 10, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 10, 2014CANCELLED SECTION 71
Thursday, August 28, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 2, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 2, 2007FINAL DISPOSITION PROCESSED
Monday, October 29, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 5, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, March 20, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 28, 2007NOTICE OF PUBLICATION
Thursday, February 1, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 31, 2007ASSIGNED TO LIE
Thursday, December 28, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 15, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 15, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 15, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 29, 2006REFUSAL PROCESSED BY IB
Thursday, September 7, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 7, 2006REFUSAL PROCESSED BY MPU
Wednesday, September 6, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 5, 2006NON-FINAL ACTION WRITTEN
Tuesday, September 5, 2006ASSIGNED TO EXAMINER
Friday, June 16, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, June 15, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

leakadine modulating immune response diseases dermatological preparations treatment cancer pharmaceutical